Fanconi Anemia
Hematology·MeSH: Bone Marrow Failure Disorders
Prevalence
0.5 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| rp-l102 | Rocket Pharmaceuticals Inc. (RCKT) |
Frequently asked questions
How many drugs are in development for Fanconi Anemia?
BioSniper tracks 1 drug in development for Fanconi Anemia across 1 company.
How many clinical trials target Fanconi Anemia?
There are 3 clinical trials targeting Fanconi Anemia tracked by BioSniper.
What is the prevalence of Fanconi Anemia?
The estimated prevalence of Fanconi Anemia is approximately 0.5 per 100,000 population.
Deep-dive into Fanconi Anemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis